25 XP   0   0   10

Cumberland Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Cumberland Pharmaceuticals Inc together

PenkeI guess you are interested in Cumberland Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cumberland Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cumberland Pharmaceuticals Inc

I send you an email if I find something interesting about Cumberland Pharmaceuticals Inc.

Quick analysis of Cumberland Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Cumberland Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$2.05
Expected worth in 1 year
$0.35
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-1.70
Return On Investment
-96.3%

For what price can you sell your share?

Current Price per Share
$1.76
Expected price per share
$1.43 - $2.2328
How sure are you?
50%

1. Valuation of Cumberland Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$1.76

Intrinsic Value Per Share

$3.40 - $7.71

Total Value Per Share

$5.45 - $9.76

2. Growth of Cumberland Pharmaceuticals Inc (5 min.)




Is Cumberland Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$29.2m$35.9m-$6.7m-22.9%

How much money is Cumberland Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.2m-$5.6m-$629.2k-10.0%
Net Profit Margin-15.9%-13.4%--

How much money comes from the company's main activities?

3. Financial Health of Cumberland Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Cumberland Pharmaceuticals Inc? (5 min.)

Welcome investor! Cumberland Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Cumberland Pharmaceuticals Inc.

What can you expect buying and holding a share of Cumberland Pharmaceuticals Inc?

First you should know what it really means to hold a share of Cumberland Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Cumberland Pharmaceuticals Inc is $1.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cumberland Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cumberland Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.05. Based on the TTM, the Book Value Change Per Share is $-0.42 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cumberland Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.44-25.0%-0.44-25.0%-0.38-21.7%-0.30-17.1%-0.23-13.3%
Usd Book Value Change Per Share-0.42-24.1%-0.42-24.1%-0.39-22.1%-0.30-17.2%-0.23-12.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.3620.4%
Usd Total Gains Per Share-0.42-24.1%-0.42-24.1%-0.39-22.1%-0.30-17.1%0.137.5%
Usd Price Per Share1.79-1.79-2.25-3.36-4.69-
Price to Earnings Ratio-4.08--4.08--5.88--13.12--2.12-
Price-to-Total Gains Ratio-4.23--4.23--5.80--13.00-22.22-
Price to Book Ratio0.88-0.88-0.91-1.19-1.32-
Price-to-Total Gains Ratio-4.23--4.23--5.80--13.00-22.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.76
Number of shares568
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.42-0.30
Usd Total Gains Per Share-0.42-0.30
Gains per Quarter (568 shares)-240.73-170.83
Gains per Year (568 shares)-962.90-683.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-963-9734-687-693
20-1926-19368-1375-1376
30-2889-289912-2062-2059
40-3852-386216-2749-2742
50-4815-482520-3437-3425
60-5777-578824-4124-4108
70-6740-675128-4812-4791
80-7703-771432-5499-5474
90-8666-867737-6186-6157
100-9629-964041-6874-6840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%10.09.00.052.6%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%10.09.00.052.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.08.020.0%3.00.016.015.8%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%11.08.00.057.9%

Fundamentals of Cumberland Pharmaceuticals Inc

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Fundamental data was last updated by Penke on 2024-04-11 04:50:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Cumberland Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cumberland Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -15.9% means that $-0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is -15.9%. The company is making a huge loss. -2
  • The TTM is -15.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-15.9%0.0%
TTM-15.9%YOY-13.4%-2.4%
TTM-15.9%5Y-17.9%+2.0%
5Y-17.9%10Y-12.0%-5.9%
1.1.2. Return on Assets

Shows how efficient Cumberland Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.7% Return on Assets means that Cumberland Pharmaceuticals Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is -7.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.7%TTM-7.7%0.0%
TTM-7.7%YOY-6.1%-1.6%
TTM-7.7%5Y-7.2%-0.5%
5Y-7.2%10Y-4.8%-2.4%
1.1.3. Return on Equity

Shows how efficient Cumberland Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -21.2% Return on Equity means Cumberland Pharmaceuticals Inc generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.2%TTM-21.2%0.0%
TTM-21.2%YOY-15.6%-5.6%
TTM-21.2%5Y-16.4%-4.8%
5Y-16.4%10Y-10.4%-6.0%

1.2. Operating Efficiency of Cumberland Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cumberland Pharmaceuticals Inc is operating .

  • Measures how much profit Cumberland Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -16.4% means the company generated $-0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is -16.4%. The company is operating very inefficient. -2
  • The TTM is -16.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16.4%TTM-16.4%0.0%
TTM-16.4%YOY-13.6%-2.8%
TTM-16.4%5Y-19.1%+2.7%
5Y-19.1%10Y-11.1%-8.0%
1.2.2. Operating Ratio

Measures how efficient Cumberland Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are $1.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is 1.164. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.164. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.164TTM1.1640.000
TTM1.164YOY1.136+0.028
TTM1.1645Y1.191-0.027
5Y1.19110Y1.115+0.076

1.3. Liquidity of Cumberland Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cumberland Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.28 means the company has $1.28 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is 1.276. The company is just able to pay all its short-term debts.
  • The TTM is 1.276. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.2760.000
TTM1.276YOY1.605-0.329
TTM1.2765Y1.855-0.579
5Y1.85510Y3.084-1.229
1.3.2. Quick Ratio

Measures if Cumberland Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is 1.003. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.003. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.003TTM1.0030.000
TTM1.003YOY1.152-0.148
TTM1.0035Y1.371-0.368
5Y1.37110Y2.862-1.491

1.4. Solvency of Cumberland Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cumberland Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cumberland Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.64 means that Cumberland Pharmaceuticals Inc assets are financed with 64.2% credit (debt) and the remaining percentage (100% - 64.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is 0.642. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.642. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.642TTM0.6420.000
TTM0.642YOY0.613+0.029
TTM0.6425Y0.555+0.087
5Y0.55510Y0.413+0.142
1.4.2. Debt to Equity Ratio

Measures if Cumberland Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 177.4% means that company has $1.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cumberland Pharmaceuticals Inc:

  • The MRQ is 1.774. The company is just able to pay all its debts with equity.
  • The TTM is 1.774. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.774TTM1.7740.000
TTM1.774YOY1.570+0.204
TTM1.7745Y1.285+0.489
5Y1.28510Y0.856+0.429

2. Market Valuation of Cumberland Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cumberland Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Cumberland Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -4.08 means the investor is paying $-4.08 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cumberland Pharmaceuticals Inc:

  • The EOD is -4.008. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.080. Based on the earnings, the company is expensive. -2
  • The TTM is -4.080. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.008MRQ-4.080+0.072
MRQ-4.080TTM-4.0800.000
TTM-4.080YOY-5.883+1.803
TTM-4.0805Y-13.123+9.043
5Y-13.12310Y-2.124-10.999
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cumberland Pharmaceuticals Inc:

  • The EOD is 4.461. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.542. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.542. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.461MRQ4.542-0.080
MRQ4.542TTM4.5420.000
TTM4.542YOY5.136-0.595
TTM4.5425Y14.755-10.213
5Y14.75510Y-6.211+20.966
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cumberland Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cumberland Pharmaceuticals Inc:

  • The EOD is 0.860. Based on the equity, the company is cheap. +2
  • The MRQ is 0.876. Based on the equity, the company is cheap. +2
  • The TTM is 0.876. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.860MRQ0.876-0.015
MRQ0.876TTM0.8760.000
TTM0.876YOY0.911-0.035
TTM0.8765Y1.185-0.310
5Y1.18510Y1.317-0.132
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cumberland Pharmaceuticals Inc.

3.1. Institutions holding Cumberland Pharmaceuticals Inc

Institutions are holding 15.654% of the shares of Cumberland Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp3.87870.0015549863-5900-1.0616
2023-12-31Vanguard Group Inc2.6399037425111250.3015
2023-12-31Dimensional Fund Advisors, Inc.2.58130.0002365934-13786-3.6306
2023-12-31Bridgeway Capital Management, LLC2.0220.010728665500
2023-12-31Acadian Asset Management LLC1.32730.001318816400
2023-12-31BlackRock Inc0.7829011099000
2023-12-31Geode Capital Management, LLC0.601508527400
2023-12-31Bank of New York Mellon Corp0.530907526800
2023-12-31State Street Corporation0.280703979000
2023-12-31Two Sigma Investments LLC0.2330.000133030-200-0.6019
2023-12-31Two Sigma Advisers, LLC0.16510.000123400-200-0.8475
2023-12-31Northern Trust Corp0.1283018189-1635-8.2476
2023-12-31Cresset Asset Management, LLC0.08480.00011202510009.0703
2023-12-31Morgan Stanley - Brokerage Accounts0.079501127400
2023-12-31Wiley Bros.-Aintree Capital, LLC0.07760.004811000110000
2023-09-30Citadel Advisors Llc0.041905933-13776-69.897
2023-12-31Tower Research Capital LLC0.03970.0001562859611.8442
2023-12-31Oakworth Capital Inc0.02150.0004305200
2023-12-31SIMPLEX TRADING, LLC0.001702372370
2023-12-31Royal Bank of Canada0.0010138-10-6.7568
Total 15.51930.01932200095-21549-1.0%

3.2. Funds holding Cumberland Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.9809028082000
2023-12-31Bridgeway Ultra-Small Company1.6440.467923306800
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.59420.00028424400
2024-02-29DFA US Targeted Value I0.56230.00137972000
2023-12-31Bridgeway Ultra-Small Company Market0.35190.04674988700
2024-02-29DFA US Micro Cap I0.3370.00144777200
2024-03-29Dimensional US Targeted Value ETF0.32680.00084632700
2024-02-29Fidelity Extended Market Index0.29790.000242231-205-0.4831
2024-02-29DFA US Core Equity 2 I0.21710.00023077100
2024-02-29DFA US Vector Equity I0.16610.0012354800
2024-03-29Dimensional US Marketwide Value ETF0.16450.00042331900
2024-02-29DFA US Core Equity 1 I0.15790.00012238100
2024-02-29Fidelity Series Total Market Index0.15050.000121329-752-3.4056
2024-03-29Dimensional US Small Cap ETF0.13190.00041869900
2024-02-29Dimensional Global Trgtd Value USD Acc0.10260.00061454800
2024-02-29Fidelity Nasdaq Composite Index0.07990.00021132700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07220.00031023100
2024-02-29Vanguard Balanced Index Inv0.06480918700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0580.00038217150.1829
2023-12-31SSgA U.S. Extended Market Index Class I0.0430.0004609000
Total 7.50350.52251063716-942-0.1%

3.3. Insider Transactions

Insiders are holding 45.008% of the shares of Cumberland Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-12-21James JonesBUY882.22
2022-12-19Caroline YoungBUY302.21
2022-12-16Caroline YoungBUY202.22
2022-12-14Caroline YoungBUY202.21
2022-12-12Caroline YoungBUY202.14
2022-12-09Caroline YoungBUY202.15
2022-12-07Caroline YoungBUY202.18
2022-12-05Caroline YoungBUY202.19
2022-12-01Caroline YoungBUY202.33
2022-11-28Caroline YoungBUY202.37
2022-11-25Caroline YoungBUY202.31
2022-11-23Caroline YoungBUY202.29
2022-11-21Caroline YoungBUY202.38
2022-11-18Caroline YoungBUY202.27
2022-11-16Caroline YoungBUY202.31
2022-11-14Caroline YoungBUY202.32
2022-11-11Caroline YoungBUY202.32
2022-11-09Caroline YoungBUY202.37
2022-11-07Caroline YoungBUY202.45
2022-11-04Caroline YoungBUY202.42

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cumberland Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.424-0.4240%-0.388-8%-0.303-29%-0.228-46%
Book Value Per Share--2.0462.0460%2.470-17%2.757-26%3.487-41%
Current Ratio--1.2761.2760%1.605-20%1.855-31%3.084-59%
Debt To Asset Ratio--0.6420.6420%0.613+5%0.555+16%0.413+55%
Debt To Equity Ratio--1.7741.7740%1.570+13%1.285+38%0.856+107%
Dividend Per Share----0%-0%0.002-100%0.360-100%
Eps---0.439-0.4390%-0.382-13%-0.301-31%-0.233-47%
Free Cash Flow Per Share--0.3940.3940%0.438-10%0.317+24%0.166+137%
Free Cash Flow To Equity Per Share---0.125-0.1250%0.296-142%-0.023-82%0.008-1739%
Gross Profit Margin--3.9383.9380%3.9490%3.491+13%1.818+117%
Intrinsic Value_10Y_max--7.715--------
Intrinsic Value_10Y_min--3.402--------
Intrinsic Value_1Y_max--0.491--------
Intrinsic Value_1Y_min--0.212--------
Intrinsic Value_3Y_max--1.689--------
Intrinsic Value_3Y_min--0.753--------
Intrinsic Value_5Y_max--3.147--------
Intrinsic Value_5Y_min--1.416--------
Market Cap24950640.000-3%25619113.37625619113.3760%32768082.000-22%50402223.531-49%74953215.084-66%
Net Profit Margin---0.159-0.1590%-0.134-15%-0.179+13%-0.120-24%
Operating Margin---0.164-0.1640%-0.136-17%-0.191+16%-0.111-32%
Operating Ratio--1.1641.1640%1.136+2%1.191-2%1.115+4%
Pb Ratio0.860-2%0.8760.8760%0.911-4%1.185-26%1.317-34%
Pe Ratio-4.008+2%-4.080-4.0800%-5.883+44%-13.123+222%-2.124-48%
Price Per Share1.760-2%1.7921.7920%2.250-20%3.362-47%4.694-62%
Price To Free Cash Flow Ratio4.461-2%4.5424.5420%5.136-12%14.755-69%-6.211+237%
Price To Total Gains Ratio-4.153+2%-4.228-4.2280%-5.797+37%-12.996+207%22.225-119%
Quick Ratio--1.0031.0030%1.152-13%1.371-27%2.862-65%
Return On Assets---0.077-0.0770%-0.061-21%-0.072-6%-0.048-37%
Return On Equity---0.212-0.2120%-0.156-27%-0.164-23%-0.104-51%
Total Gains Per Share---0.424-0.4240%-0.388-8%-0.301-29%0.132-422%
Usd Book Value--29259869.00029259869.0000%35974006.000-19%41158900.000-29%55597999.500-47%
Usd Book Value Change Per Share---0.424-0.4240%-0.388-8%-0.303-29%-0.228-46%
Usd Book Value Per Share--2.0462.0460%2.470-17%2.757-26%3.487-41%
Usd Dividend Per Share----0%-0%0.002-100%0.360-100%
Usd Eps---0.439-0.4390%-0.382-13%-0.301-31%-0.233-47%
Usd Free Cash Flow--5640770.0005640770.0000%6379586.000-12%4669336.200+21%2518200.200+124%
Usd Free Cash Flow Per Share--0.3940.3940%0.438-10%0.317+24%0.166+137%
Usd Free Cash Flow To Equity Per Share---0.125-0.1250%0.296-142%-0.023-82%0.008-1739%
Usd Market Cap24950640.000-3%25619113.37625619113.3760%32768082.000-22%50402223.531-49%74953215.084-66%
Usd Price Per Share1.760-2%1.7921.7920%2.250-20%3.362-47%4.694-62%
Usd Profit---6279320.000-6279320.0000%-5650039.000-10%-6672789.400+6%-4609525.700-27%
Usd Revenue--39552507.00039552507.0000%42010949.000-6%37875585.600+4%37471630.600+6%
Usd Total Gains Per Share---0.424-0.4240%-0.388-8%-0.301-29%0.132-422%
 EOD+4 -4MRQTTM+0 -0YOY+4 -305Y+13 -2310Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Cumberland Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.008
Price to Book Ratio (EOD)Between0-10.860
Net Profit Margin (MRQ)Greater than0-0.159
Operating Margin (MRQ)Greater than0-0.164
Quick Ratio (MRQ)Greater than11.003
Current Ratio (MRQ)Greater than11.276
Debt to Asset Ratio (MRQ)Less than10.642
Debt to Equity Ratio (MRQ)Less than11.774
Return on Equity (MRQ)Greater than0.15-0.212
Return on Assets (MRQ)Greater than0.05-0.077
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Cumberland Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.170
Ma 20Greater thanMa 501.669
Ma 50Greater thanMa 1001.847
Ma 100Greater thanMa 2001.881
OpenGreater thanClose1.670
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets81,776
Total Liabilities52,516
Total Stockholder Equity29,603
 As reported
Total Liabilities 52,516
Total Stockholder Equity+ 29,603
Total Assets = 81,776

Assets

Total Assets81,776
Total Current Assets35,714
Long-term Assets46,062
Total Current Assets
Cash And Cash Equivalents 18,322
Net Receivables 9,758
Inventory 4,609
Other Current Assets 3,025
Total Current Assets  (as reported)35,714
Total Current Assets  (calculated)35,714
+/-0
Long-term Assets
Property Plant Equipment 7,042
Goodwill 914
Intangible Assets 22,608
Long-term Assets Other 15,497
Long-term Assets  (as reported)46,062
Long-term Assets  (calculated)46,062
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,982
Long-term Liabilities24,534
Total Stockholder Equity29,603
Total Current Liabilities
Short-term Debt 348
Accounts payable 14,038
Other Current Liabilities 13,597
Total Current Liabilities  (as reported)27,982
Total Current Liabilities  (calculated)27,982
+/-0
Long-term Liabilities
Long term Debt 12,784
Capital Lease Obligations 5,644
Long-term Liabilities Other 274
Long-term Liabilities  (as reported)24,534
Long-term Liabilities  (calculated)18,702
+/- 5,831
Total Stockholder Equity
Common Stock47,092
Retained Earnings -17,488
Total Stockholder Equity (as reported)29,603
Total Stockholder Equity (calculated)29,603
+/-0
Other
Capital Stock47,092
Cash and Short Term Investments 18,322
Common Stock Shares Outstanding 14,299
Liabilities and Stockholders Equity 81,776
Net Debt 107
Net Invested Capital 42,388
Net Working Capital 7,732
Property Plant and Equipment Gross 9,280
Short Long Term Debt Total 18,428



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
10,173
26,481
28,919
31,119
103,724
92,054
95,518
98,594
87,614
95,405
91,919
93,405
93,232
112,694
104,549
96,463
84,460
92,925
81,776
81,77692,92584,46096,463104,549112,69493,23293,40591,91995,40587,61498,59495,51892,054103,72431,11928,91926,48110,173
   > Total Current Assets 
8,591
12,643
14,789
17,710
93,174
81,039
87,308
87,232
68,680
70,815
67,112
65,545
68,685
74,865
50,163
49,970
45,688
45,870
35,714
35,71445,87045,68849,97050,16374,86568,68565,54567,11270,81568,68087,23287,30881,03993,17417,71014,78912,6438,591
       Cash And Cash Equivalents 
5,536
6,255
10,815
11,830
78,702
65,894
70,599
54,349
40,869
39,866
38,203
34,510
45,413
27,939
28,213
24,754
27,041
19,758
18,322
18,32219,75827,04124,75428,21327,93945,41334,51038,20339,86640,86954,34970,59965,89478,70211,83010,8156,2555,536
       Short-term Investments 
0
0
0
0
0
0
0
16,686
14,020
14,841
14,564
15,622
4,672
8,291
0
0
0
0
0
000008,2914,67215,62214,56414,84114,02016,6860000000
       Net Receivables 
2,415
5,120
2,374
3,129
6,177
5,145
7,083
6,017
4,530
5,505
6,077
7,330
8,395
7,844
7,859
12,378
6,877
13,164
9,758
9,75813,1646,87712,3787,8597,8448,3957,3306,0775,5054,5306,0177,0835,1456,1773,1292,3745,1202,415
       Inventory 
546
671
949
1,763
4,823
7,684
5,775
6,218
5,723
5,600
4,270
5,372
6,738
27,827
8,871
10,638
8,430
9,400
4,609
4,6099,4008,43010,6388,87127,8276,7385,3724,2705,6005,7236,2185,7757,6844,8231,763949671546
       Other Current Assets 
21
48
651
989
3,472
979
3,851
1,671
826
1,351
1,469
2,711
3,467
2,964
2,757
2,200
3,340
3,549
3,025
3,0253,5493,3402,2002,7572,9643,4672,7111,4691,3518261,6713,8519793,4729896514821
   > Long-term Assets 
1,582
13,838
14,130
13,409
10,551
11,015
8,210
11,361
18,934
24,590
24,807
27,859
24,547
37,829
54,386
46,494
38,772
47,055
46,062
46,06247,05538,77246,49454,38637,82924,54727,85924,80724,59018,93411,3618,21011,01510,55113,40914,13013,8381,582
       Property Plant Equipment 
374
366
460
432
918
1,220
1,119
1,189
881
651
536
464
529
771
3,708
2,602
1,467
5,502
7,042
7,0425,5021,4672,6023,7087715294645366518811,1891,1191,220918432460366374
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
784
882
882
882
914
914
9149148828828827840000000000000
       Intangible Assets 
37
9,834
9,154
8,529
7,956
7,427
7,023
9,477
15,499
21,569
21,169
22,154
21,445
33,655
30,920
28,118
23,954
30,591
22,608
22,60830,59123,95428,11830,92033,65521,44522,15421,16921,56915,4999,4777,0237,4277,9568,5299,1549,83437
       Other Assets 
0
0
4,516
4,448
1,676
2,368
68
695
2,555
2,370
3,102
5,241
2,574
18,368
18,876
17,801
12,468
10,048
0
010,04812,46817,80118,87618,3682,5745,2413,1022,3702,555695682,3681,6764,4484,51600
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
50
1,209
0
1,211
3,120
87
87
22
0
0
0
0
00002287873,1201,21101,209500000000
> Total Liabilities 
3,940
15,355
12,172
13,564
31,503
14,339
12,683
13,027
8,322
14,652
15,099
20,284
29,311
57,123
53,464
49,590
41,858
56,951
52,516
52,51656,95141,85849,59053,46457,12329,31120,28415,09914,6528,32213,02712,68314,33931,50313,56412,17215,3553,940
   > Total Current Liabilities 
2,951
8,698
8,119
7,606
18,624
9,228
6,600
8,055
7,546
13,749
12,412
14,792
17,695
27,804
24,150
25,667
19,279
28,580
27,982
27,98228,58019,27925,66724,15027,80417,69514,79212,41213,7497,5468,0556,6009,22818,6247,6068,1198,6982,951
       Short-term Debt 
281
1,833
3,159
1,250
9,207
2,691
0
0
0
0
1,700
4,100
9,800
0
920
1,017
970
173
348
3481739701,01792009,8004,1001,70000002,6919,2071,2503,1591,833281
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,700
4,100
9,800
0
0
2,187
0
0
0
0002,187009,8004,1001,7000000000000
       Accounts payable 
990
3,373
1,921
3,257
5,633
2,125
1,514
2,791
2,036
3,243
2,877
8,037
8,980
11,093
9,994
13,396
9,641
10,819
14,038
14,03810,8199,64113,3969,99411,0938,9808,0372,8773,2432,0362,7911,5142,1255,6333,2571,9213,373990
       Other Current Liabilities 
1,127
2,053
410
458
3,785
25
5,086
5,265
5,510
10,507
9,534
6,756
8,715
16,711
7,736
11,254
8,668
17,588
13,597
13,59717,5888,66811,2547,73616,7118,7156,7569,53410,5075,5105,2655,086253,7854584102,0531,127
   > Long-term Liabilities 
989
6,657
4,053
5,958
12,879
5,111
6,083
4,972
776
903
2,687
5,491
11,616
29,319
29,314
23,922
22,579
28,371
24,534
24,53428,37122,57923,92229,31429,31911,6165,4912,6879037764,9726,0835,11112,8795,9584,0536,657989
       Long term Debt Total 
0
0
0
0
0
0
4,860
4,360
0
0
1,700
4,100
9,800
20,000
18,500
15,000
0
0
0
00015,00018,50020,0009,8004,1001,700004,3604,860000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
50
1,209
0
1,211
3,120
87
87
22
0
0
0
0
00002287873,1201,21101,209500000000
       Other Liabilities 
0
0
3,137
382
185
618
578
613
776
903
987
1,391
1,816
9,319
8,737
7,863
7,489
7,585
0
07,5857,4897,8638,7379,3191,8161,3919879037766135786181853823,13700
       Deferred Long Term Liability 
0
0
0
0
0
0
645
0
0
0
0
0
0
0
0
0
0
0
0
000000000000645000000
> Total Stockholder Equity
6,234
11,126
16,746
17,555
72,254
77,778
82,929
85,696
79,468
80,761
76,888
73,248
64,120
55,845
51,123
46,991
42,814
36,266
29,603
29,60336,26642,81446,99151,12355,84564,12073,24876,88880,76179,46885,69682,92977,77872,25417,55516,74611,1266,234
   Common Stock
0
0
17,319
13,500
1,930,000
70,779
70,272
67,197
63,074
61,942
57,338
54,643
52,411
51,099
49,914
49,122
48,453
47,475
47,092
47,09247,47548,45349,12249,91451,09952,41154,64357,33861,94263,07467,19770,27270,7791,930,00013,50017,31900
   Retained Earnings 
-11,764
-7,360
-3,316
1,451
4,542
6,999
12,657
18,499
16,395
18,818
19,550
18,605
11,709
4,746
1,208
-2,131
-5,639
-11,209
-17,488
-17,488-11,209-5,639-2,1311,2084,74611,70918,60519,55018,81816,39518,49912,6576,9994,5421,451-3,316-7,360-11,764
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
15,255
15,743
17,319
13,500
-1,862,288
70,779
-2,533,728
1,441
1,847
2,240
2,497
2,700
2,911
3,125
3,394
0
-212
0
0
00-21203,3943,1252,9112,7002,4972,2401,8471,441-2,533,72870,779-1,862,28813,50017,31915,74315,255



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue39,553
Cost of Revenue-11,003
Gross Profit28,55028,550
 
Operating Income (+$)
Gross Profit28,550
Operating Expense-35,031
Operating Income-6,481-6,481
 
Operating Expense (+$)
Research Development5,834
Selling General Administrative10,652
Selling And Marketing Expenses18,452
Operating Expense35,03134,938
 
Net Interest Income (+$)
Interest Income252
Interest Expense-668
Other Finance Cost-1
Net Interest Income-417
 
Pretax Income (+$)
Operating Income-6,481
Net Interest Income-417
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,285-6,678
EBIT - interestExpense = -7,149
-6,234
-5,611
Interest Expense668
Earnings Before Interest and Taxes (EBIT)-6,481-5,617
Earnings Before Interest and Taxes (EBITDA)-711
 
After tax Income (+$)
Income Before Tax-6,285
Tax Provision-69
Net Income From Continuing Ops-2,488-6,354
Net Income-6,279
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses46,034
Total Other Income/Expenses Net196417
 

Technical Analysis of Cumberland Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cumberland Pharmaceuticals Inc. The general trend of Cumberland Pharmaceuticals Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cumberland Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cumberland Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.9 < 2.1 < 2.2328.

The bearish price targets are: 1.49 > 1.43 > 1.43.

Tweet this
Cumberland Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cumberland Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cumberland Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cumberland Pharmaceuticals Inc. The current macd is -0.04357386.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cumberland Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cumberland Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cumberland Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cumberland Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartCumberland Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cumberland Pharmaceuticals Inc. The current adx is 15.41.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cumberland Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cumberland Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cumberland Pharmaceuticals Inc. The current sar is 1.52503799.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cumberland Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cumberland Pharmaceuticals Inc. The current rsi is 54.17. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Cumberland Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartCumberland Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cumberland Pharmaceuticals Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cumberland Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cumberland Pharmaceuticals Inc Daily Stochastic Oscillator ChartCumberland Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cumberland Pharmaceuticals Inc. The current cci is 76.00.

Cumberland Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartCumberland Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cumberland Pharmaceuticals Inc. The current cmo is 23.99.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cumberland Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartCumberland Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cumberland Pharmaceuticals Inc. The current willr is -20.58823529.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cumberland Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cumberland Pharmaceuticals Inc Daily Williams %R ChartCumberland Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cumberland Pharmaceuticals Inc. The current atr is 0.1026715.

Cumberland Pharmaceuticals Inc Daily Average True Range (ATR) ChartCumberland Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cumberland Pharmaceuticals Inc. The current obv is 249,101.

Cumberland Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartCumberland Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cumberland Pharmaceuticals Inc. The current mfi is 28.64.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cumberland Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartCumberland Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cumberland Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Cumberland Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cumberland Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.170
Ma 20Greater thanMa 501.669
Ma 50Greater thanMa 1001.847
Ma 100Greater thanMa 2001.881
OpenGreater thanClose1.670
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cumberland Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Cumberland Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cumberland Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cumberland Pharmaceuticals Inc

I send you an email if I find something interesting about Cumberland Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cumberland Pharmaceuticals Inc.

Receive notifications about Cumberland Pharmaceuticals Inc in your mailbox!